This is only for those on the oral version, and has very little relevance to those on the injectables Zepbound and Wegovy
Not everyone taking GLP-1 medications will feel worn out, but some people may develop fatigue (persistent exhaustion that doesnt improve with rest)
Incretin-based therapies for type 2 diabetes: a focus on glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
A variety of GLP-1RAs agents are currently available, including exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and the dual GLP-1/GIP receptor agonist, tirzepatide
Who should not use Retatrutide
Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A